NTA has played an increasing role in the facilitation of clinical trials and provided services to support a number of investigator-initiated and commercially sponsored clinical phase II and III studies in the following areas:

• Secondary Stroke Prevention
• Acute Stroke
• Pain
• Multiple Sclerosis

We have also supported bids for studies in:

• Parkinson’s Disease
• Epilepsy
• Alzheimer’s Disease
• Mild Cognitive Impairment
• Migraine
• Neurosurgery